Streetbeat News

Analyst Ratings

CLX

Over the past three months, 9 analysts have shared their insights on Clorox (NYSE:CLX), with opinions ranging from bullish to bearish. The average 12-month price target has increased by 6.09% to $154.89. Clorox has shown a 27.13% revenue growth rate, but faces challenges with a low net margin and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

OPCH

Option Care Health (NASDAQ:OPCH) has received mixed analyst ratings over the past three months, with a shift towards more bullish sentiments recently. Analysts have lowered their 12-month price targets, with an average target of $33.8, down from $39.00. Despite this, the company shows strong financial performance with significant revenue growth, high net margins, and efficient debt management.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

COHU

TD Cowen analyst Krish Sankar maintains a Buy rating on Cohu (NASDAQ:COHU) but lowers the price target from $36 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:58 pm

CCO

TD Cowen analyst Lance Vitanza maintains a Buy rating on Clear Channel Outdoor (NYSE:CCO) but lowers the price target from $2.6 to $2.4.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:57 pm

ROOT

Wells Fargo analyst Elyse Greenspan has maintained an Equal-Weight rating on Root (NASDAQ:ROOT) and increased the price target from $64 to $78.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:51 pm

GDYN

TD Cowen analyst Bryan Bergin maintains a Buy rating on Grid Dynamics Holdings (NASDAQ:GDYN) and raises the price target from $16 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:51 pm

CMCSA

TD Cowen analyst Gregory Williams maintains a Buy rating on Comcast (NASDAQ:CMCSA) but lowers the price target from $50 to $48.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:49 pm

ADP

TD Cowen analyst Bryan Bergin maintains a Hold rating on Automatic Data Processing (ADP) and raises the price target from $276 to $285.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:46 pm

NWPX

Northland Capital Markets has downgraded Northwest Pipe (NASDAQ:NWPX) from Outperform to Market Perform, while maintaining the price target at $50.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:45 pm

MRK

Wells Fargo analyst Mohit Bansal has maintained an Equal-Weight rating on Merck & Co (NYSE:MRK) but has lowered the price target from $125 to $110.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 6:45 pm